Study
46 patients primary malignant glioma cohort in Chinese population
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001005583 | Other |
Study Description
We recruited 46 Chinese patients with primary malignant glioma. All the patients were analyzed with whole-exome sequencing (WES) and 27 of them were analyzed with RNA-seq. We compared the molecular features between patients in different WHO grades. We used six-month progression-free survival (PFS6) status to group glioblastoma (GBM) patients to a good and a poor survival compared two groups genomic profiles.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001008115 |
the source data in VCF format of 46 patients primary malignant glioma cohort in Chinese population
|
45 |
Who archives the data?
Publications
Citations
Retrieving...
Retrieving...
